Trial intelligence / Profile preview

Bioequivalence of mosapride citrate 5 mg film-coated tablets in healthy Thai volunteers under fasting conditions

TCTR20210714001Phase 1Completed

Sponsor
Unison Laboratories
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of mosapride (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 2 more. Started Oct 2021; status: completed.

02

Drugs

mosapride

Beyond the preview

Go deeper on TCTR20210714001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210714001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call